Page 48 - Maturity Date News Today

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION...

SOCIÉTÉ GÉNÉRALE SFH € 70,000,000,000 Euro Medium Term Note Programme for the issue... | April 19, 2023

Item 1.01 Entry into a Material Definitive Agreement. On April 13, 2023, Palo Alto Networks, Inc. entered into a Credit Agreement , by and among the Company, the lenders from time to time party... | April 19, 2023

On April 19, 2023 Nasdaq Riga will run a competitive multi-price auction where will be offered 3.500 per cent. Notes due 2028 (to be consolidated and form a single series with the existing EUR 945,000

The following discussion and analysis of our results of operations and financial condition for the fiscal years ended December 31, 2022 and 2021, should be read in conjunction with our consolidated... | April 17, 2023

Cease Trade Order BULLETIN DATE: April 14, 2023 TSX Venture Company A Cease Trade Order has been issued by the by the and Securities Commissions on April 13, 2023, against the following Company for failing to file the document indicated within the... - Veroeffentlicht am 15.04.2023

, 04/12/2023 / 16:00, EST/EDT - EQS Newswire - Tryp Therapeutics Inc. (Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Canadian Stock Exchange, Nasdaq OTC)KELOWNA, BC / ACCESSWIRE / April 12, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage...

PROMISSORY NOTE US $2,000,000.00 April 7, 2023 ... | April 12, 2023

Articles of Association of Ascendis Pharma A/S Name,... | April 12, 2023

12.04.2023 - KELOWNA, BC / ACCESSWIRE / April 12, 2023 / Tryp Therapeutics Inc. (Tryp or the Company) (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases ... Seite 1